NDC 24208-040-02 - Xipere
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 24208-040
- Requested NDC
- 24208-040-02
- Package NDCs from labels
- 24208-040-41, 24208-040-40, 24208-040-02, 24208-040-01
- Manufacturer
- Bausch & Lomb Incorporated | Alcami Carolinas Corporation
- Effective date
- 2025-10-08
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Xipere - Bausch & Lomb Incorporated | Alcami Carolinas Corporation | Bausch & Lomb Incorporated | Alcami Carolinas Corporation | 2025-10-08 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 24208-040-01 | Xipere | 1 in 1 CARTON | INJECTION, SUSPENSION | 1 | 7 | |
| 24208-040-01 | Xipere | 1 in 1 TRAY | INJECTION, SUSPENSION | 1 | 7 | |
| 24208-040-02 | Xipere | 0.9 mL in 1 VIAL | INJECTION, SUSPENSION | 0.9 | 7 | |
| 24208-040-40 | Xipere | 1 in 1 CARTON | INJECTION, SUSPENSION | 1 | 7 | |
| 24208-040-40 | Xipere | 1 in 1 TRAY | INJECTION, SUSPENSION | 1 | 7 | |
| 24208-040-41 | Xipere | 0.9 mL in 1 VIAL | INJECTION, SUSPENSION | 0.9 | 7 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 24208-040-40 | ML - Milliliter | 24208-040 | da6c08ed-251c-4030-bfaf-2d7e536d5c98 | 1 | 2023-01-09 |
| 24208-040-41 | ML - Milliliter | 24208-040 | 676b47a3-48f2-4885-932c-12f0b33f42bd | 1 | 2023-04-07 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Lymph Tonic II | ECHINACEA (ANGUSTIFOLIA), COLLINSONIA CANADENSIS, PHYTOLACCA DECANDRA, KALI IODATUM, PINUS SYLVESTRIS, PIX LIQUIDA, FERRUM PHOSPHORICUM, AESCULUS HIPPOCASTANUM, BARYTA CARBONICA, BERBERIS VULGARIS, CALCAREA CARBONICA, CALCAREA PHOSPHORICA, CAUSTICUM, HEPAR SULPHURIS CALCAREUM, KREOSOTUM, LYCOPODIUM CLAVATUM, MERCURIUS SOLUBILIS, NATRUM MURIATICUM, NITRICUM ACIDUM, PHOSPHORUS, PULSATILLA (PRATENSIS), SILICEA, STELLARIA MEDIA, SULPHUR, TEREBINTHINA, THUJA OCCIDENTALIS, BUFO RANA | BioActive Nutritional, Inc. | 0e3265b0-b210-4a4c-80d2-8a9712981d4e | 2026-09-17 | Warnings | 451W47IQ8X |
| calcium chloride | CALCIUM CHLORIDE | Eskayef Pharmaceuticals Limited | 5b0bd762-4c87-597e-e063-6394a90a8303 | 2026-09-09 | Warnings, Adverse reactions | M4I0D6VV5M |
| TheraTears | CARBOXYMETHYLCELLULOSE SODIUM | MEDTECH PRODUCTS INC | 17a01236-130f-495b-9f8d-92b6a23b2dc5 | 2026-09-09 | Warnings | K679OBS311 |
| Potassium Chloride Extended-release | POTASSIUM CHLORIDE EXTENDED-RELEASE | REMEDYREPACK INC. | ace1eb11-b925-405a-b772-58c60b3ca7d4 | 2026-09-09 | Warnings, Adverse reactions | 660YQ98I10 |
| Saline | NASAL | Raritan Pharmaceuiticals Inc | 4b178e4e-a10f-4b75-8140-1f7548e203ad | 2026-09-09 | Warnings | 451W47IQ8X |
| Thyroid Support | CALCAREA CARBONICA, CALCAREA IODATA, CAUSTICUM, FERRUM IODATUM, FUCUS VESICULOSUS, KALI IODATUM, NATRUM MURIATICUM, THYROIDINUM (BOVINE) | NaturalCare | 07b4e0ed-2b00-4d0a-ad8f-fc6deff15325 | 2026-09-08 | Warnings | 451W47IQ8X |
| Nerve Guard Nerve Relief | LIDOCAINE HYDROCHLORIDE, MENTHOL,MAGNESIUM CHLORIDE | Micelle Laboratories, Incorporated | 6b78f40f-2a7f-4c49-96af-1a95acbf430f | 2026-09-04 | Warnings | 02F3473H9O |
| Psoriasis Control | CENTELLA ASIATICA, SODIUM CHLORIDE, AND SILICON DIOXIDE | Forces of Nature | 2db33771-0bb9-49f8-84fa-dddc28e4ba26 | 2026-09-04 | Warnings | 451W47IQ8X |
| KROGER Saline | NASAL | KROGER COMPANY | c84b242b-f46e-4ea8-a3c1-109a47644646 | 2026-09-02 | Warnings | 451W47IQ8X |
| Triamcinolone acetonide | TRIAMCINOLONE ACETONIDE | Redpharm Drug | 5a79639b-eb66-e726-e063-6394a90aeb01 | 2026-09-02 | Adverse reactions | F446C597KA |
| Adrenal Support | ADRENALINUM, ARGENTUM NITRICUM, BERBERIS VULGARIS, NATRUM MURIATICUM, OLEUM MORRHUAE, PETROLEUM, VANADIUM | NaturalCare | 31a5d522-15cd-432a-bf87-f721bcbe2e31 | 2026-09-02 | Warnings | 451W47IQ8X |
| Xtreme Saline Rinse Mix | SODIUM BICARBONATE, SODIUM CHLORIDE | Xtreme Personal Care Inc | 776f417e-e443-4918-8c7a-1913b7dddcd4 | 2026-09-01 | Warnings | 451W47IQ8X |
| Nacl 0.9% Normal Saline Solution | SODIUM CHLORIDE | CHI FUNG TECHNOLOGY COMPANY | 5a53c4c8-c9de-700c-e063-6394a90a3ab5 | 2026-08-31 | Warnings | 451W47IQ8X |
| BMNP Kali Mur | KALIUM MURIATICUM | Total Operations Management LLC DBA:Bestmade Natural Products Micro | 5a546950-3f03-7abf-e063-6294a90a1968 | 2026-08-31 | Warnings | 660YQ98I10 |
| BMNP Nat Mur | NATRUM MURIATICUM | Total Operations Management LLC DBA:Bestmade Natural Products Micro | 5a57ccfd-ab6f-cb2c-e063-6394a90ae9e6 | 2026-08-31 | Warnings | 451W47IQ8X |
| Triamcinolone acetonide | TRIAMCINOLONE ACETONIDE | REMEDYREPACK INC. | d10b5451-5685-489e-b123-55c99d33c5b2 | 2026-08-31 | Adverse reactions | F446C597KA |
| Calcium Chloride | CALCIUM CHLORIDE | REMEDYREPACK INC. | 801f110c-7800-4689-a37a-f31d99c0f930 | 2026-08-28 | Adverse reactions | M4I0D6VV5M |
| REFRESH LIQUIGEL | CARBOXYMETHYLCELLULOSE SODIUM | Allergan, Inc. | 4b8b2f6a-4b89-446c-9e5b-9b83c453a01d | 2026-08-28 | Warnings | K679OBS311 |
| Allergy Care | ADRENALINUM, RAGWEED, POLLEN (AMBROSIA ARTEMISIAEFOLIA), APIS MELLIFICA, ECHINACEA (ANGUSTIFOLIA), HISTAMINUM HYDROCHLORICUM, LEDUM PALUSTRE, LYCOPODIUM CLAVATUM, NATRUM MURIATICUM, SULPHUR | NaturalCare | f3ca7f5a-1448-4670-ac02-b47ffb6c5585 | 2026-08-27 | Warnings | 451W47IQ8X |
| Potassium Chloride Extended-release | POTASSIUM CHLORIDE EXTENDED-RELEASE | REMEDYREPACK INC. | 2c407aaf-5d95-49ff-a5db-f1d7b5190334 | 2026-08-27 | Warnings, Adverse reactions | 660YQ98I10 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.